Catheter Precision (VTAK) Short-term Investments (2019 - 2020)
Catheter Precision (VTAK) reported Short-term Investments of $5.0 million for Q1 2020, down 68.72% quarter-over-quarter from $16.0 million in Q4 2019.
Catheter Precision (VTAK) Short-term Investments (2019 - 2020) Analysis & Trends
Catheter Precision (VTAK) has 2 years of Short-term Investments data on file, last reported at $5.0 million in Q1 2020.
- Short-term Investments for Q1 2020 came in at $5.0 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2020 was $5.0 million (changed N/A YoY), and the FY2019 annual result was $16.0 million, changed N/A from the prior year.
- Short-term Investments declined to $5.0 million in Q1 2020 per VTAK's latest filing, from $16.0 million in the prior quarter.
- Over five years, Short-term Investments peaked at $36.6 million in Q2 2019 and troughed at $5.0 million in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Catheter Precision | 1.19 Mn | 381,424.70 | 390,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 5.00 Mn |
| Dec 31, 2019 | 15.99 Mn |
| Sep 30, 2019 | 25.96 Mn |
| Jun 30, 2019 | 36.60 Mn |